Frontlight ResearchEarly access
Trial site
Seattle Clinical Research Center
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Migraine6 trials
- Obesity3 trials
- Chronic spontaneous urticaria1 trial
- Cytomegalovirus infection1 trial
- Obstructive sleep apnoea1 trial
- Osteoporosis1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Completed3 trials
- Active, not recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Novo Nordisk A/S2 trials
- Pfizer2 trials
- TriGemX Bio, Inc.2 trials
- AbbVie1 trial
- Biohaven Therapeutics Ltd.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Migraine2 recruiting
- Obstructive sleep apnoea1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026